Clinical Trial Update: REDUCER Trial (TXA in Urethroplasty) [Phase 4]

View source ↗

Summary

Phase 4 REDUCER trial evaluating tranexamic acid in urethroplasty; status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urethral Disease
• Urethral Stricture

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Amjad Alwaal, MD, MSc, FRCSC, FACS | Conditions: Urethral Stricture, Urethral Diseases | Phase 4 | Status: NOT_YET_RECRUITING